Intelligence · Clinical Development
Pipeline search results
Programs matching “air” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 160 pipeline programs matching "air" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
VX-880 solution for infusion
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia
1 trial -
2020/3093 NIRADO
The George Institute
DNA repair-deficient or platinum-sensitive solid tumors
1 trial -
202000570
Disc Medicine
Metastatic solid tumors, these may include but are not limited to melanoma, non-small-cell lung carcinoma (NSCLC), cervical cancer, microsatellite instable (MSI)-high/deficient mismatch repair (dMMR) cancer, renal cell carcinoma (RCC), CSCC, urothelial cell carcer (UCC), small cell lung cancer (SCLC) and head and neck squamous cell carcinoma (HNSCC).
1 trial -
60 mg Prednisone
United Therapeutics Europe Ltd
Airway Inflammation
1 trial -
ACU193-201
Acumen Pharmaceuticals
Early Alzheimer’s Disease (Mild Cognitive Impairment and Mild Dementia Due to Alzheimer’s Disease)
1 trial -
AIR DNase™
Protalix BioTherapeutics
Cystic Fibrosis
1 trial -
AIRC Id. 21939
Fondazione Telethon ETS
Metastatic DTC
1 trial -
Advair HFA
United Therapeutics Europe Ltd
Altitude Edema
1 trial -
Air médical en bouteille, OXYGEN
Pari Pharma GmbH
Alternating Hemiplegia of Childhood
1 trial -
Atorvastatin Oral Tablet
Chongqing Precision Biotech Co., Ltd
Mild Cognitive Impairment
1 trial -
BIS-001ER
SUPERNUS PHARMACEUTICALS, INC.
Focal Impaired Awareness Seizures
1 trial -
CAAA617A12202
Novartis Pharmaceuticals
Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) with moderate and severe renal impairment and with normal renal function.
1 trial -
CR6086-1-04
Alphapharm Pty Ltd
Pretreated mismatch-repair-proficient and microsatellite stable metastatic colorectal cancer, and other metastatic GI cancers
1 trial -
EAE116
Wuhan Createrna Science and Technology Co., Ltd
Newly diagnosed patients with multiple myeloma and severe renal impairment
1 trial -
EYP001-210
Lacuna Pharma Pty Ltd
Impaired renal function and suspected MASH
1 trial -
Febuxostat
Takeda
Renal Impairment
1 trial -
ICO-2020-01 REPAIR
CERO THERAPEUTICS HOLDINGS, INC.
RElapse in previously irradiated Prostate bed
1 trial -
IIBSP-HEA-2022-145
The George Institute
cognitive impairment
1 trial -
KEYTRUDA 25 mg/mL concentrate for solution for infusion
Disc Medicine
Mismatch repair deficient endometrial cancer / uterine cancer
1 trial -
Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG
MEDA Pharma GmbH & Co. KG
Mild Cognitive impairment due to Alzheimer Disease
1 trial -
Rapamune 1 mg/mL oral solution
Tour Hekla
Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations, presenting as clusters of cysts filled with lymph fluid or blood. They are responsible for a heavy burden even with small well-limited lesions because of oozing, bleeding, infections, or even speech, chewing or breathing impairment. Pain and aesthetic prejudice are also frequently reported
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Mild Cognitive Impairment
1 trial -
Senicapoc
BRIGHT MINDS BIOSCIENCES INC.
Mild Cognitive Impairment
1 trial -
Tiragolumab for HNSCC, metastatic deficient mis…
Disc Medicine
HNSCC, metastatic deficient mismatch repair (dMMR)/MSI-high (MSI-H) tumors, irresectable or metastatic melanoma, locally advanced or metastatic solid tumor
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.